Search

Search Results
Results 2061 - 2070 of 2159 for Abuse potential
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Paracetamol/Codeine GH 500/30 intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Panadeine Forte intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Comfarol Forte intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about Codapane Forte intended for persons living in Australia.
  • Drug - 9 Sep 2024
    Consumer Medicine Information (CMI) about APX-Paracetamol/Codeine intended for persons living in Australia.
  • Drug - 24 Jul 2024
    Consumer Medicine Information (CMI) about Nupentin Capsules intended for persons living in Australia.
  • Health - 2 Jul 2024
    Early puberty is associated with increasing odds of chronic disease, both physical and mental. Menarche at 10 vs 11 years, for instance, roughly doubles the odds of long-term ill-health in adult life....
  • White Paper - 6 Jun 2024
    Scitegrity, the makers of Controlled Substances Squared, a software platform and website for identifying whether a chemical is a controlled substance, has announced an upgrade to the legislation...
  • Drug - 24 Apr 2024
    Consumer Medicine Information (CMI) about Paxam intended for persons living in Australia.
  • Drug - 23 Apr 2024
    Consumer Medicine Information (CMI) about Iclusig intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.